Affiliation:
1. Department of Nuclear Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India
Abstract
AbstractRosai-Dorfman disease (RDD) is a rare benign proliferative disorder. Lymph nodes are the usual and common sites of involvement. Involvement of the extranodal site is also documented in the literature. 18F-fluorodeoxyglucose positron emission tomography computed tomography (F18-FDG PET CT) is a valuable whole-body imaging modality in staging and treatment response of various lymphoproliferative and solid organ malignancy. Similarly, PET CT survey can detect the involved sites of various body systems, infective or inflammatory diseases, and provide guidance for biopsy and to reach to diagnosis. Here, we present a case of RDD, who presented with neurological manifestations and on F18-FDG PET CT, diagnosed with multiorgan involvement.
Reference23 articles.
1. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease;O Abla;Blood,2018
2. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity;J Rosai;Arch Pathol,1969
3. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): imaging manifestations in the head and neck;D V La Barge III;AJR Am J Roentgenol,2008
4. Rosai-Dorfman disease: self-resolving unilateral lymphadenopathy and a brief review of literature;J Feriante;Case Rep Oncol Med,2018
5. 18F-FDG PET/CT follow-up of Rosai-Dorfman disease;D Albano;Clin Nucl Med,2015